Camelot Portfolios Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.91M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$2.21M |
| 3 |
Amazon
AMZN
|
+$1.63M |
| 4 |
Eli Lilly
LLY
|
+$1.42M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MidCap Financial Investment
MFIC
|
+$366K |
| 2 |
Citigroup
C
|
+$271K |
| 3 |
Invesco Senior Income Trust
VVR
|
+$267K |
| 4 |
Chewy
CHWY
|
+$162K |
| 5 |
Mercury Systems
MRCY
|
+$94.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.82% |
| 2 | Consumer Discretionary | 9.44% |
| 3 | Healthcare | 6.09% |
| 4 | Financials | 5.72% |
| 5 | Industrials | 5.48% |
Similar funds
Camelot Portfolios's Q2 2024 Portfolio in Review
As of Q2 2024, Camelot Portfolios held 601 positions worth $177M, up 73% from $102M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Camelot Portfolios deployed $76.6M of net new capital in Q2 2024, opening 459 new positions and adding to 110 existing holdings. Its largest new stake was Eli Lilly: 1,775 shares worth $1.61M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 57% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was MidCap Financial Investment, an estimated $366K trimmed.
- Camelot Portfolios's largest Q2 2024 buy was Eli Lilly: 1,775 shares worth $1.61M.
- Camelot Portfolios added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2024, an estimated $5.91M increase.
- Camelot Portfolios's biggest Q2 2024 reduction was MidCap Financial Investment, cutting an estimated $366K.
- Camelot Portfolios fully exited Chewy in Q2 2024, selling an estimated $162K.
- Camelot Portfolios's ten largest holdings make up 23% of its $177M portfolio in Q2 2024.
- Camelot Portfolios opened 459 new positions and closed 1 in Q2 2024.
- Camelot Portfolios's portfolio value rose 73% quarter-over-quarter to $177M.
Based on Camelot Portfolios's 13F filing for Q2 2024, filed 12 Aug 2024.